Overview

Comparative Study of the Effects of Dry Needling and Botulinum Toxin Type A as a Treatment for Lower Limb Post-stroke Spasticity

Status:
RECRUITING

Trial end date:
2025-12-31

Target enrollment:

Participant gender:

Summary

This is a randomized parallel group clinical trial which will be conducted in three countries (Spain, Canada and Belgium) comparing Botulinum Toxin type A (BTX-A) and Dry Needling (DN) effectiveness for post-stroke spasticity in participants who had a first stroke in the previous 12 months and have plantar flexor spasticity. Participants will be randomly allocated to receive either one session of BTX-A or 12 weekly sessions of DN. Blinded evaluators will assess the effects before, during, and after treatment, and at a 4-week follow-up.

Phase:

PHASE2

Details

Lead Sponsor:

Universiteit Antwerpen

Collaborators:

Fonds de la Recherche en Santé du Québec
Instituto de Investigación Sanitaria Aragón
Instituto de Salud Carlos III
McGill University
Research Foundation Flanders

Treatments:

Botulinum Toxins, Type A
Dry Needling